India has seen a significant rise in Foreign Direct Investment, attracting USD 843 billion between 2014-15 and 2025-26. Key government init...

The government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...

Helios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...

India and Oman's new trade pact unlocks significant export potential for sectors like textiles, gems, and marine products. This agreement a...

Union Minister Piyush Goyal said he held a meeting with Janet Truncale, Global Chair and CEO of EY, to discuss India's growing role in glob...

Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...

India is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...

Despite these disruptions, companies like EPL Ltd, Uflex, and TCPL Packaging remain optimistic about FY27 growth, driven by strong domestic...

Uzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbe...

In a bold move towards self-sufficiency, India is ramping up its domestic manufacturing initiatives! Six government-led teams are tasked wi...

India is boosting domestic manufacturing. Six expert groups will identify 100 products to reduce import dependence. This initiative aims to...

Market expert Neeraj Dewan advises selective investing amid volatility, favoring power, energy infrastructure, steel, aviation, commercial ...

Nifty 50 earnings growth fell short of expectations in FY25 and FY26. While Q4 FY26 results led to an upward revision for FY27E Nifty 50 EP...

Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...

Indian corporate earnings are meeting expectations, but market sentiment is subdued due to broader economic concerns, not company performan...

Nine women now earn over one million dollars annually as C-suite executives. Domestic companies are leading this rise, reflecting a focus o...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...